Cataract surgery in the face of ocular surface disease

Current Opinion in Ophthalmology

Volumn 23, Issue 1, 2012, Pages 68-72

  Movahedan, Asadolah ^a   Djalilian, Ali R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Blepharitis; Cataract surgery; Dry eye; Lid margin disease; Ocular surface disease

Indexed keywords

ANTIINFLAMMATORY AGENT; AZITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; DICLOFENAC; DOXYCYCLINE; FLUORESCEIN; IMMUNOMODULATING AGENT; KETOROLAC; LINSEED OIL; MINOCYCLINE; NEPAFENAC; OMEGA 3 FATTY ACID; TETRACYCLINE;

ANTIBIOTIC THERAPY; BLEPHARITIS; CATARACT EXTRACTION; CLINICAL EXAMINATION; COMPLICATION; CONJUNCTIVITIS; CORNEA DISEASE; CORNEAL MELTING; CORNEAL STAINING; DIABETIC PATIENT; DIAGNOSTIC TEST; DISEASE CONTROL; DRUG MECHANISM; DRY EYE; ENDOPHTHALMITIS; EYE DISEASE; EYE LAVAGE; GRAFT VERSUS HOST REACTION; HUMAN; NEUROTROPHIC CORNEAL DISEASE; OCULAR CICATRICIAL PEMPHIGOID; OCULAR SURFACE DISEASE; PEMPHIGOID; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SJOEGREN SYNDROME; STAINING; STEVENS JOHNSON SYNDROME; VISUAL DISORDER; PERIOPERATIVE PERIOD;

CATARACT EXTRACTION; DRY EYE SYNDROMES; EYE DISEASES; HUMANS; PERIOPERATIVE CARE;

EID: 84856618093     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32834d90b7     Document Type: Review

References (48)

1. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136:318-326. (Pubitemid 36904081)
2. Han SB, Hyon JY, Woo SJ, et al. Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol 2011; 129:633-638.
3. Cho YK, Kim MS. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol 2009; 23:65-73.
4. Li XM, Hu L, Hu J, Wang W. Clinical observation of dry eye in patients before and after cataract surgery. Zhonghua Yan Ke Za Zhi 2007; 43:10-13.
5. Ram J, Gupta A, Brar G, et al. Outcomes of phacoemulsification in patients with dry eye. J Cataract Refract Surg 2002; 28:1386-1389. (Pubitemid 37022448)
6. Khanal S, Tomlinson A, Esakowitz L, et al. Changes in corneal sensitivity and tear physiology after phacoemulsification. Ophthalmic Physiol Opt 2008; 28:127-134. (Pubitemid 351388686)
7. Li XM, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea 2007; 26:S16-S20. (Pubitemid 47442757)
8. Korb DR. Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 2000; 19:483-486. (Pubitemid 30460885)
9. Nichols KK, Nichols JJ, Zadnik K. Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice. Cornea 2000; 19:477-482. (Pubitemid 30460884)
10. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995; 21:221-232.
11. Roberts CW, Elie ER. Dry eye symptoms following cataract surgery. Insight 2007; 32:14-21; quiz 22-23.
12. Bjerrum KB. Test and symptoms in keratoconjunctivitis sicca and their correlation. Acta Ophthalmol Scand 1996; 74:436-441. (Pubitemid 26390485)
13. Hay EM, Thomas E, Pal B, et al. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: Results from a population based study. Ann Rheum Dis 1998; 57:20-24. (Pubitemid 28175215)
14. Serin D, Karsloǧlu S, Kyan A, Alagöz G. A simple approach to the repeatability of the Schirmer test without anesthesia: Eyes open or closed? Cornea 2007; 26:903-906. (Pubitemid 47329790)
15. Hardten DR. Dry eye disease in patients after cataract surgery. Cornea 2008; 27:855.
16. Lockwood A, Hope-Ross M, Chell P. Neurotrophic keratopathy and diabetes mellitus. Eye 2006; 20:837-839. (Pubitemid 44316996)
17. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: A Delphi approach to treatment recommendations. Cornea 2006; 25:900-907. (Pubitemid 44763848)
18. Sánchez MA, Arriola-Villalobos P, Torralbo-Jiménez P, et al. The effect of preservative-free HP-Guar on dry eye after phacoemulsification: A flow cytometric study. Eye 2010; 24:1331-1337.
19. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004; 137:337-342. (Pubitemid 38221009)
20. Pflugfelder SC, Maskin SL, Anderson B, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 2004; 138:444-457. (Pubitemid 39208573)
21. Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea 2008; 27:64-69.
22. Sahli E, Hoşal BM, Zilelioǧlu G, Gülbahçe R, et al. The effect of topical cyclosporine A on clinical findings and cytological grade of the disease in patients with dry eye. Cornea 2010; 29:1412-1416.
23. Donnenfeld ED, Solomon R, Roberts CW, et al. Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation. J Cataract Refract Surg 2010; 36:1095-1100. This randomized, prospective, contralaterally controlled, double-masked trial is one of the most important studies that evaluate the effect of treatment of ocular surface disease in cataract patients. One important feature is that it focuses on visual outcome and patient's satisfaction.
24. Su MY, Perry HD, Barsam A, et al. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy. Cornea 2011; 30:1098-1104. Decreasing the dosage of topical cyclosporine with the same therapeutic effect promises improved quality of life and better maintenance for dry eye patients.
25. Gilbard JP, Rossi SR, Azar DT, Heyda KG. Effect of punctal occlusion by Freeman silicone plug insertion on tear osmolarity in dry eye disorders. CLAO J 1989; 15:216-218. (Pubitemid 19201044)
26. Roberts CW, Carniglia PE, Brazzo BG. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. Cornea 2007; 26:805-809. (Pubitemid 47220551)
27. Stead RE, Stuart A, Keller J, Subramaniam S. Reducing the rate of cataract surgery cancellation due to blepharitis. Eye 2010; 24:742.
28. Speaker MG, Milch FA, Shah MK, et al. The role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991; 98:639-649.
29. Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther 2008; 25:858-870.
30. Jackson WB. Blepharitis, current strategies for diagnosis and management. Can J Ophthalmol 2008, 43:170-179. (Pubitemid 351518168)
31. Alvarenga LS, Mannis MJ. Ocular rosacea. Ocul Surf 2005; 3:41-58. (Pubitemid 40347579)
32. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: Patient characteristics and follow-up. Ophthalmology 1997; 104:1863-1867. (Pubitemid 28100343)
33. Zengin N, Tol H, Gündüz K, et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea 1995; 14:144-146.
34. Lindstrom RL. The effects of blepharitis on ocular surgery. Ocul Surf 2009; 7:S19-S20.
35. Chen YA, Hirnschall N, Findl O. Comparison of corneal wetting properties of viscous eye lubricant and balanced salt solution to maintain optical clarity during cataract surgery. J Cataract Refract Surg 2011; 37:1806- 1808. A clear view of a surgeon is critical in any ophthalmic surgery. Intraoperative BSS irrigation might not always provide the best optical clarity. It also tends to evaporate rapidly, thus making the ocular surface prone to desiccation stress. This article suggests using HMPC 2%, addresses both of these disadvantages.
36. Lyne A. Corneal sensitivity after surgery. Trans Ophthalmol Soc UK 1982; 102:302-305. (Pubitemid 13172101)
37. John T. Corneal sensation after small incision, sutureless, one-handed phacoemulsification. J Cataract Refract Surg 1995; 21:425-428.
38. Kohlhaas M, Stahlhut O, Tholuck J, Richard G. Development of corneal sensitivity after phacoemulsification with scleral tunnel incision. Klin Monbl Augenheilkd 1997; 211:32-36. (Pubitemid 27405064)
39. Moon SW, Yeom DJ, Chung SH. Neurotrophic corneal ulcer development following cataract surgery with a limbal relaxing incision. Korean J Ophthalmol 2011; 25:210-213.
40. Wolf EJ, Kleiman LZ, Schrier A. Nepafenac-associated corneal melt. J Cataract Refract Surg 2007; 33:1974-1975. (Pubitemid 47615363)
41. Khalifa YM, Mifflin MD. Keratitis and corneal melt with ketorolac tromethamine after conductive keratoplasty. Cornea 2011; 30:477-478.
42. Gokhale NS, Vemuganti GK. Diclofenac-induced acute corneal melt after collagen crosslinking for keratoconus. Cornea 2010; 29:117-119.
43. Pfister RR, Murphy GE. Corneal ulceration and perforation associated with Sjögren's syndrome. Arch Ophthalmol 1980; 98:89-94. (Pubitemid 10160260)
44. Cohen KL. Sterile corneal perforation after cataract surgery in Sjögren's syndrome. Br J Ophthalmol 1982; 66:179-182. (Pubitemid 12176897)
45. Perez VL, Azar DT, Foster CS. Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol 2002; 17:124-130. (Pubitemid 36514794)
46. Van der Meulen IJ, van Rooij J, Hazes JW, et al. Corneal melting after ocular surgery in patients with auto-immune disorders. Ned Tijdschr Geneeskd 2007; 151:920-923. (Pubitemid 46713022)
47. Sangwan VS, Burman S. Cataract surgery in Stevens-Johnson syndrome. J Cataract Refract Surg 2005; 31:860-862. (Pubitemid 40719436)
48. Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm 2007; 15:99-104. (Pubitemid 46897685)